Status:
COMPLETED
Ultrasound Evaluation Versus Direct Measurement of Uterine Cavity Length
Lead Sponsor:
Children's Mercy Hospital Kansas City
Conditions:
Dysmenorrhea
Heavy Menstrual Bleeding
Eligibility:
FEMALE
12-22 years
Phase:
NA
Brief Summary
To determine if uterine cavity length on transabdominal pelvic ultrasound corresponds to uterine cavity length at time of IUD insertion. If transabdominal pelvic ultrasound is validated as a tool for ...
Detailed Description
Levonogesterel (progestin only) IUDs have been used in the adult population for decades and due to their safety and efficacy are now successfully used in the nulliparous and adolescent population for ...
Eligibility Criteria
Inclusion
- Females age 12 - 22 years old at time of transabdominal ultrasound whom are being considered for IUD placement as part of routine clinical care will be approached for inclusion in the study.
- IUD inserted between 12/1/19 and 12/1/20
- Received a transabdominal US of the uterus
Exclusion
- US never performed
- Mullerian anomaly
Key Trial Info
Start Date :
January 6 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2023
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT04425577
Start Date
January 6 2020
End Date
February 1 2023
Last Update
February 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Mercy Hospital
Kansas City, Missouri, United States, 64108